For Immediate Release
Chicago, IL – October 13, 2016 – Zacks Value Investor is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here:( https://www.zacks.com/stock/
Is Brexit a Buying Opportunity?
Welcome to Episode #13 of the Value Investor Podcast
Every week, Zacks value stock strategist and the Editor of Zacks Value Investor portfolio service, Tracey Ryniec, talks about all things happening in the value stock universe, including her top stock picks.
This week, Tracey discusses how value investors need to look for buying opportunities. Value investors buy in industries and sectors everyone else is scared of. Fear is the value investor’s friend.
Right now, one of the most fearful parts of the global economy is in Great Britain. The Brexit vote is continuing to have investment ramifications as questions swirl about whether it will be a difficult separation or not.
The British pound just suffered one of the top 40 worst 4-day periods in its history, as it fell nearly 5%. It is at 1985 lows.
A value investor might ask: are British stocks being hit just as badly?
And if so, are there some buying opportunities there?
Tracey looks at the ways you can get into the game including through buying British companies that are trading on the US stock exchanges as well as through buying country-specific ETFs. The ETFs give you more diversified exposure.
Are British Stocks on Sale?
1. GlaxoSmithKline (NYSE: GSK -Free Report ) has a forward P/E of 16.7. It also pays a dividend yielding 4.6%.
2. AstraZeneca (NYSE: AZN -Free Report ) is trading with a forward P/E of 15.5. Shareholders are rewarded with dividends yielding 4.3%.
3. British American Tobacco (LON:BATS) (NYSEMKT: BTI -Free Report ) isn’t very cheap. It has a forward P/E of 19.
Tracey is also keeping a couple of stocks on her “watch” list. Which ones does she think have potential?
What About Country ETFs?
1. iShares United Kingdom ETF (NYSEARCA: EWU - Free Report ) : specializes in mid-and-large cap companies. Only down 3% on the year.
2. iShares United Kingdom ETF (BATS:EWUS - Free Report ): focuses on 240 small cap companies. It is down 12% year-to-date.
Tracey believes there is a buying opportunity in one of these. Which one does she like?
Check out this week’s podcast to find out what values may lurk in the British Isles.
Want more insights from Tracey?
Check out her weekly Value Investor service to receive more in-depth analysis on value companies and see which stocks she thinks are the best bargains now. Click here to learn more>>
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Click here for your free subscription to Profit from the Pros.
Get the full Report on GSK - FREE
Get the full Report on AZN - FREE
Get the full Report on BTI - FREE
Get the full Report on EWU - FREE
Get the full Report on EWUS - FREE
Follow us on Twitter: https://twitter.com/zacksresearch
Join us on Facebook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
https://www.zacks.com/performance
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
GLAXOSMITHKLINE (GSK): Free Stock Analysis Report
ASTRAZENECA PLC (AZN): Free Stock Analysis Report
BRITISH AM TOB (BTI): Free Stock Analysis Report
ISHARS-UTD KING (EWU): ETF Research Reports
ISHARS-MS UK SC (EWUS): ETF Research Reports
Original post